COVID-19 Clinical Trials in the Philippines:

Opportunities and Challenges

Anna M S L Ordinario
Head of Site Management & Monitoring, R&D (AstraZeneca Phils)
Disclaimer:
The statements in this presentation reflect a personal opinion and do not present official policy
or procedures of PCRP nor companies the speaker is working for or has worked for.
 Clinical Trial Landscape in the Philippines

Courtesy of PCRP, Inc

~1,000 ~300 ~1,400 FDA New Normal Processes

investigators institutions trials
IATF for the Management of Emerging Infection Diseases
Resolution No.65 for CT applications and zoning guidance
Source: TrialTrove and SiteTrove| Informa Pharma
Intelligence, accessed 17 September 2020
7 for COVID-19 Vaccines
COVID-
19 trials
 Opportunities and Challenges

16,514 trials
340,000 trials globally in 2019
globally 0.2% 38
233 trials in
trials in PH 3,156
~1,400 34
trials in TH
trials VN
COVID-19
0.4% trials globally
Source: TrialTrove and SiteTrove| Informa Pharma
Why is this important? 7
Intelligence, accessed 17 September 2020 Determinants for Country Selection: trials
▪ Registration requirements in PH
▪ Protocol design / Patient Population
▪ Country ‘attractiveness’
Opportunities and Challenges

Imagine
Highly Regulated yourself as
More Controls a patient
Mirrors our health care system challenges
Thank you!

PCRP Clinical Trial Management during

COVID-19
Open Letter to Policy Makers on Clinical
Trials Regulations in the Philippines
during the COVID-19 Pandemic
https://pcrp.org.ph/pcrp-clinical-trial-
management-during-covid-19-
newsletter/